Fertility medicine has undergone a quiet but profound transformation in recent years. Where conventional reproductive endocrinology has long focused on pharmaceutical and surgical interventions as the primary tools for addressing infertility, an emerging class of regenerative therapies is offering something qualitatively different: the possibility of restoring the biological conditions that support natural reproductive function. At the forefront of these regenerative approaches is PRP therapy, which has emerged as one of the most scientifically compelling and clinically promising options available to those individuals navigating the complex challenges of fertility and reproductive health.
At The Longevity Centers, PRP therapy is applied within a comprehensive, root-cause framework that treats reproductive health not as an isolated clinical concern, but as an expression of whole-body physiological vitality. It could be both a stand-alone solution to infertility issues, as well as a valuable complement to other therapies.
What Is PRP Therapy?
PRP therapy, or “platelet-rich plasma therapy,” is a regenerative therapy that utilizes a concentrated preparation of the patient’s own blood components to stimulate tissue repair, cellular regeneration, and localized healing responses. The process begins with a standard blood draw, after which the sample is placed in a centrifuge that separates its constituent elements by density. The resulting platelet-rich plasma, a fraction of the blood that contains a concentration of platelets greater than baseline levels, is then prepared for therapeutic application.1
Platelets are best known for their role in clotting, but their regenerative significance extends far beyond wound sealing. Platelets are dense repositories of growth factors, bioactive proteins that coordinate tissue repair, stimulate stem cell recruitment, promote angiogenesis, and regulate the inflammatory environment of damaged or aging tissue.2
When delivered to reproductive tissues—including the ovaries and uterine lining—this concentrated cocktail of growth factors can help create a biochemical environment that is conducive to cellular regeneration, vascular development, and the restoration of tissue function that may have been compromised by aging, inflammation, autoimmune processes, or prior medical intervention.
Why Choose LCOA
What Sets Longevity Centers of America Apart?
- Personalized protocols tailored to your unique health goals
- Physician-led team with advanced training in functional and longevity medicine
- In-depth testing and root-cause diagnostics
- Concierge-level care and long-term support
- Proven therapies backed by science
- A calm, comfortable, and discreet environment
Clinical PRP Therapy Applications for Fertility and Reproductive Health
PRP therapy can be potentially used to support a range of fertility and reproductive health concerns.
Diminished Ovarian Reserve
Women experiencing diminished ovarian reserve—whether due to the natural progression of age, premature ovarian insufficiency, or the effects of prior medical treatment—are primary candidates for PRP therapy. Intraovarian PRP therapy has been associated with measurable improvements in key markers of ovarian function and with the restoration of ovarian activity in women who had previously been told that their reproductive options were severely limited or exhausted.3
Repeated Implantation Failure
PRP therapy has shown promising results for women who have experienced multiple failed embryo transfers, despite the availability of high-quality embryos. Delivered to the uterine cavity in the days preceding embryo transfer can optimize endometrial receptivity, improving the likelihood of successful implantation.4
Premature Ovarian Insufficiency
The loss of normal ovarian function before the age of forty is one of the most challenging scenarios in reproductive medicine, with conventional options largely limited to donor egg IVF or hormone treatments. Intraovarian PRP therapy has emerged as an increasingly studied intervention for women with premature ovarian insufficiency (POI), with the potential of restoring partial ovarian function.5
Support for IVF Cycles
PRP therapy can also be an impactful support for women undergoing in vitro fertilization. As mentioned, the therapy can be used to optimize both ovarian response to stimulation and endometrial preparation for embryo transfer. The goal is the enhancement of the biological conditions that determine cycle outcomes.
The PRP Therapy Process
For individuals seeking PRP therapy, The Longevity Centers offer a structured evaluation and therapy process built around a thorough understanding of each patient’s unique reproductive and physiological profile. Therapy is never initiated without the clinical context necessary to ensure it is appropriate. This process involves:
- Comprehensive reproductive and hormonal assessment: Includes a uterine evaluation and a look at relevant metabolic and inflammatory markers
- Clinical consultation and individualized planning: A detailed review of reproductive history, prior fertility treatments, and current health status to help determine the most appropriate application of PRP therapy
- Blood draw and PRP preparation: A standard venous blood draw, followed by centrifugal preparation of the platelet-rich plasma under controlled conditions, to ensure consistent concentration and quality
- Targeted delivery: Intraovarian injection under ultrasound guidance to ensure precision, patient comfort, and procedural safety
- Follow-up assessment: Regular monitoring of reproductive hormone levels, ultrasound parameters, and clinical response to evaluate the impact of therapy and guide decisions about repeat sessions or complementary therapies
Most patients tolerate PRP therapy procedures well. Because the therapy utilizes the patient’s own biological material, the risk of reaction or other adverse effects is minimal. Some degree of localized discomfort during or following intraovarian injection is common and typically resolves promptly.
Frequently Asked Questions
What is PRP therapy, and how is it different from other fertility treatments?
PRP therapy, or “platelet-rich plasma” therapy, is a regenerative therapy that uses a concentrated preparation of the patient’s own blood-derived growth factors to stimulate tissue repair and cellular regeneration in reproductive organs. Unlike conventional fertility treatments, which typically work by pharmacologically stimulating existing ovarian function or bypassing natural reproductive processes altogether, PRP therapy aims to restore and improve the underlying biological capacity of the ovaries. It addresses the tissue-level environment of reproduction rather than simply compensating for its limitations, making it a fundamentally different and complementary category of intervention.
Who is a good candidate for PRP therapy for fertility?
Individuals who may benefit from PRP therapy for fertility include women with diminished ovarian reserve, low AMH, elevated FSH, premature ovarian insufficiency, recurrent implantation failure, or a history of uterine surgery or intrauterine adhesions. PRP therapy is also often sought out by women preparing for IVF cycles, who wish to optimize both ovarian response and endometrial receptivity.
How many PRP therapy sessions are typically needed for fertility purposes?
The number of PRP therapy sessions required varies depending on the specific challenges, the severity of the underlying issue, and the individual patient’s response to therapy. Some patients may achieve meaningful improvement following just one to two sessions. Others with more significant issues, like ovarian insufficiency or structural uterine concerns, may benefit from a series of sessions over a period of several months. Your care team at The Longevity Centers will develop a personalized plan and monitor your response through serial laboratory and ultrasound assessments.
Does PRP therapy carry any significant risks or side effects?
Because PRP therapy is derived entirely from the patient’s own blood, the risk of allergic reaction, immune rejection, or systemic adverse effects is exceptionally low. The most commonly reported side effects are localized: mild discomfort, cramping, or pressure at the site of injection or infusion, all of which typically resolve within hours to a day following the procedure. All therapies at The Longevity Centers are performed by trained clinical staff under appropriate guidance and monitoring protocols to ensure the highest standards of procedural safety and patient comfort.
References
- Peter Everts, Kentaro Onishi, Prathap Jayaram, et al., “Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020,” International Journal of Molecular Sciences, October 2020, https://pmc.ncbi.nlm.nih.gov/articles/PMC7589810/.
- R. Hariprasad, T.L. Suganya, Serin Sarah John, et al., “Assessment of Growth Factors with Three Different Platelet Preparations, Namely Platelet-Rich Fibrin, Platelet-Rich Plasma, and Lyophilized Platelet: An In vitro Study,” Journal of Pharmacy & BioAllied Sciences, November 2021, https://pmc.ncbi.nlm.nih.gov/articles/PMC8686862/.
- Efthalia Moustakli, Anastasios Potiris, Athanasios Zikopoulos, et al., “Platelet-Rich Plasma (PRP) in Reproductive Medicine: A Critical Review of PRP Therapy in Low-Reserve and Premature Ovarian Insufficiency,” Biomedicines, May 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC12109040/.
- Maki Kusumi, Tatsuji Ihana, Takako Kurosawa, et al., “Intrauterine administration of platelet‐rich plasma improves embryo implantation by increasing the endometrial thickness in women with repeated implantation failure: A single‐arm self‐controlled trial,” Reproductive Medicine and Biology, June 2020, https://pmc.ncbi.nlm.nih.gov/articles/PMC7542012/.
- “Primary Ovarian Insufficiency,” MedlinePlus.gov, January 2026, https://medlineplus.gov/primaryovarianinsufficiency.html.